Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

miR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells.

Macquarrie KL, Yao Z, Young JM, Cao Y, Tapscott SJ.

Skelet Muscle. 2012 Apr 29;2(1):7. doi: 10.1186/2044-5040-2-7.

PMID:
22541669
[PubMed]
Free PMC Article
2.

[New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?].

Tintignac LA, Leibovitch MP, Leibovitch SA.

Bull Cancer. 2001 Jun;88(6):545-8. Review. French.

PMID:
11459700
[PubMed - indexed for MEDLINE]
3.

Growth hormone and the insulin-like growth factor system in myogenesis.

Florini JR, Ewton DZ, Coolican SA.

Endocr Rev. 1996 Oct;17(5):481-517. Review.

PMID:
8897022
[PubMed - indexed for MEDLINE]
4.

Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.

Kitzmann M, Fernandez A.

Cell Mol Life Sci. 2001 Apr;58(4):571-9. Review.

PMID:
11361092
[PubMed - indexed for MEDLINE]
5.

Mechanisms of impaired differentiation in rhabdomyosarcoma.

Keller C, Guttridge DC.

FEBS J. 2013 Sep;280(17):4323-34. doi: 10.1111/febs.12421. Epub 2013 Jul 31. Review.

PMID:
23822136
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk